Global Botulinum Toxin & HA Dermal Filler Market Research Report 2022

Botulinum Toxin (Botox or BTX) is a poisonous natural protein, created by the bacteria named Clostridium Botulinum. Generally, botulinum toxin is used by the surgeons to obstruct the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction. According to the exotoxins, botulinum toxin can be classified into eight product types including botulinum toxin A, B, C1, D, E, F, G and H.
Due to the COVID-19 pandemic, the global Botulinum Toxin & HA Dermal Filler market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Botulinum Toxin & HA Dermal Filler market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Botulinum Toxin & HA Dermal Filler landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The U.S. emerged as a major region for the botulinum toxin and HA dermal fillers market, due to increased demand for minimally invasive or non-invasive facial cosmetic procedures by the residents of the U.S. supported by growth in their respective disposable income and increased tertiary health care concerns with the development of ageing symptoms.
This report focuses on Botulinum Toxin & HA Dermal Filler volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Botulinum Toxin & HA Dermal Filler market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Botulinum Toxin & HA Dermal Filler Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Botulinum Toxin
HA Dermal Filler
Segment by Application
Men
Women
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Allergan
Ipsen
Shanghai Haohai Biological Technology
Medytox